DeepBio DeepDx® Prostate
Overview
DeepDx® Prostate is a clinically validated and CE-marked AI diagnostic support software for prostate cancer. The software analyzes digitized slide images of Hematoxylin & Eosin (H&E) stained prostate specimens to detect and localize areas of interest. These areas of interest are detected based on their severity in accordance with the Gleason Scoring System. DeepDx® Prostate generates consistency as a diagnostics support software. It is designed to alleviate the shortage of pathologists and their heavy workload, while reducing diagnostic subjectivity and variability.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-based diagnostics support including ROI detection, Gleason scores, grade group, and quantification of important matrix
- Fast and accurate analysis (30 seconds per core) with 99% sensitivity and 97% specificity
- Clinically validated and CE-marked
- Approved by Korea MFDS and CE marked
- Versatile deployment: Cloud & On-Premise
- Colored overlays for Gleason patterns 3, 4, and 5
- Tumor & pattern quantification (proportions of each Gleason pattern, tumor-to-tissue ratios)
- Real-time modification of quantitative metrics as annotations are made
- Annotation tools for modifying AI analysis results and automatic measurements of total tissue and tumor lengths
- Detection of adverse histological features: Cribriform Pattern 4, Intraductal Carcinoma (IDC-P), Perineural Invasion (PNI), and High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)
Use Cases
- Automated detection and localization of prostate cancer lesions in H&E stained prostate specimens
- Automated histological grading based on the Gleason system and ISUP Grade Groups
- Quantification of tumor involvement and key metrics for prognosis
- Assisting pathologists in tumor severity determination and confirmation of diagnoses
- Reducing diagnostic subjectivity and variability among pathologists
- Streamlining research workflows and standardizing data in prostate cancer research
Details
| Category | N/A |
| Pricing | Unknown — unknown |
| Deployment | Cloud & On-Premise |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status |
Unknown DeepDx® Prostate has received FDA clearance for AI-assisted prostate cancer grading. DeepDx-Prostate Pro also received a Class 3 in-vitro diagnostic medical device approval from the Ministry of Food and Drug Safety (Korean FDA), marking it as the first AI-based medical device globally to assist in classifying prostate cancer severity. |
| Integrations | |
| EHR | Not specified |
| Specialties | All specialties |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate DeepBio DeepDx® Prostate
Videos
Product demos, reviews, and walkthroughs for DeepBio DeepDx® Prostate.
No FAQs available yet for this tool.